ONLINE DATABASE SEARCH - OI-LS-307-MEMO
1. 44228 OI-LS-307; PUBMED-OI-10/20/2004
The TRK1 potassium transporter is the critical target for killing of candida albicans by the cationic protein, histatin 5
Baev, D, Rivetta, A, Vylkova, S, Sun, JN, Zeng, GF, Slayman, CL, and Edgerton, M
J Biol Chem 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15485849&dopt=abstract
2. 44229 OI-LS-307; SCIFINDER-OI-10/14/2004
Antimicrobial formulation comprising microthecin or derivatives thereof and their uses in prevention and therapy
Morgan, Andrew John, Turner, Mark, Yu, Shukun, Weiergan, Inge, and Pedersen, Hans Christian
PATENT: WO 2004083226 ISSUE DATE: 20040930
APPLICATION: 2004 PP: 53 pp.
ASSIGNEE: (Danisco A/S, Den.
3. 44230 OI-LS-307; PUBMED-OI-10/20/2004
Fluconazole for the treatment of candidiasis: 15 years experience
Cha, R and Sobel, JD
Expert Rev Anti Infect Ther 2004. 2(3): 357-66
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15482201&dopt=abstract
4. 44231 OI-LS-307; PUBMED-OI-10/20/2004
Current and emerging therapeutic approaches to hepatitis C infection
Durantel, D, Escuret, V, and Zoulim, F
Expert Rev Anti Infect Ther 2003. 1(3): 441-54
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15482141&dopt=abstract
5. 44232 OI-LS-307; PUBMED-OI-10/20/2004
Synthesis and Potent Antimicrobial Activity of Some Novel 4-(5, 6-Dichloro-1H-benzimidazol-2-yl)-N-substituted Benzamides
Ozden, S, Karatas, H, Yildiz, S, and Goker, H
Arch Pharm (Weinheim) 2004. 337(10): 556-562
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15476288&dopt=abstract
6. 44233 OI-LS-307; PUBMED-OI-10/20/2004
Synthesis and Antimycobacterial Activity of Pyridylmethylsulfanyl and Naphthylmethylsulfanyl Derivatives of Benzazoles, 1, 2, 4-Triazole, and Pyridine-2-carbothioamide/-2-carbonitrile
Zahajska, L, Klimesova, V, Koci, J, Waisser, K, and Kaustova, J
Arch Pharm (Weinheim) 2004. 337(10): 549-555
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15476287&dopt=abstract
7. 44234 OI-LS-307; PUBMED-OI-10/20/2004
Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats
Chami, N, Chami, F, Bennis, S, Trouillas, J, and Remmal, A
Braz J Infect Dis 2004. 8(3): 217-26
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15476054&dopt=abstract
8. 44235 OI-LS-307; PUBMED-OI-10/20/2004
Crystallographic structure of PNP from Mycobacterium tuberculosis at 1.9A resolution
Nolasco, DO, Canduri, F, Pereira, JH, Cortinoz, JR, Palma, MS, Oliveira, JS, Basso, LA, de, Azevedo WF Jr, and Santos, DS
Biochem Biophys Res Commun 2004. 324(2): 789-94
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15474496&dopt=abstract
9. 44236 OI-LS-307; PUBMED-OI-10/20/2004
New method for detection of Mycobacterium tuberculosis Direct Test inhibitors in clinical specimens
Sloutsky, A, Han, LL, and Werner, BG
Diagn Microbiol Infect Dis 2004. 50(2): 109-11
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15474319&dopt=abstract
10. 44237 OI-LS-307; PUBMED-OI-10/20/2004
Screening of Compounds Toxicity against Human Monocytic cell line-THP-1 by Flow Cytometry
Pick, N, Cameron, S, Arad, D, and Av-Gay, Y
Biol Proced Online 2004. 6: 220-225
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15472722&dopt=abstract
11. 44238 OI-LS-307; PUBMED-OI-10/20/2004
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings
Moore, DA, Mendoza, D, Gilman, RH, Evans, CA, Hollm, Delgado MG, Guerra, J, Caviedes, L, Vargas, D, Ticona, E, Ortiz, J, Soto, G, and Serpa, J
J Clin Microbiol 2004. 42(10): 4432-7
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15472289&dopt=abstract
12. 44239 OI-LS-307; PUBMED-OI-10/20/2004
Branched-chain amino acid aminotransferase and methionine formation in Mycobacterium tuberculosis
Venos, ES, Knodel, MH, Radford, CL, and Berger, BJ
BMC Microbiol 2004. 4(1): 39
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15471546&dopt=abstract
13. 44240 OI-LS-307; SCIFINDER-OI-10/14/2004
Antimicrobial Chlorinated Bibenzyls from the Liverwort Riccardia marginata
Baek, Seung-Hwa, Phipps, Richard K, and Perry, Nigel B
Journal of Natural Products 2004. 67(4): 718-720
14. 44241 OI-LS-307; SCIFINDER-OI-10/14/2004
Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates
Ehrenfreund-Kleinman, Tirsta, Golenser, Jacob, and Domb, Abraham J
Biomaterials 2004. 25(15): 3049-3057
15. 44242 OI-LS-307; PUBMED-OI-10/20/2004
Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model
Chami, F, Chami, N, Bennis, S, Trouillas, J, and Remmal, A
J Antimicrob Chemother 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15456732&dopt=abstract
16. 44243 OI-LS-307; SCIFINDER-OI-10/14/2004
Antiviral furanose-type bicyclic carbohydrates
Sas, Benedikt, Van Hemel, Johan, Vandenkerckhove, Jan, Peys, Eric, Van Der Eycken, Johan, and Van Hoof, Steven
PATENT: WO 2004080410 ISSUE DATE: 20040923
APPLICATION: 2004 PP: 28 pp.
ASSIGNEE: (Kemin Pharma Europe B.V.B.A., USA
17. 44244 OI-LS-307; SCIFINDER-OI-10/14/2004
Bile acid amides derived from chiral amino alcohols: novel antimicrobials and antifungals
Hazra, Braja G, Pore, Vandana S, Dey, Sanjeev Kumar, Datta, Suchitra, Darokar, Mahendra P, Saikia, Dharmendra, Khanuja, SPS, and Thakur, Anup P
Bioorganic & Medicinal Chemistry Letters 2004. 14(3): 773-777
18. 44245 OI-LS-307; PUBMED-OI-10/20/2004
Fighting tuberculosis: An old disease with new challenges
Tripathi, RP, Tewari, N, Dwivedi, N, and Tiwari, VK
Med Res Rev 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15389729&dopt=abstract
19. 44246 OI-LS-307; PUBMED-OI-10/20/2004
DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae
Lanteri, CA, Trumpower, BL, Tidwell, RR, and Meshnick, SR
Antimicrob Agents Chemother 2004. 48(10): 3968-74
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15388460&dopt=abstract
20. 44247 OI-LS-307; PUBMED-OI-10/20/2004
Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics
Pucci, MJ, Bronson, JJ, Barrett, JF, DenBleyker, KL, Discotto, LF, Fung-Tomc, JC, and Ueda, Y
Antimicrob Agents Chemother 2004. 48(10): 3697-701
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15388422&dopt=abstract
21. 44248 OI-LS-307; PUBMED-OI-10/20/2004
Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives
Watkins, WJ, Lemoine, RC, Chong, L, Cho, A, Renau, TE, Kuo, B, Wong, V, Ludwikow, M, Garizi, N, Iqbal, N, Barnard, J, Jankowska, R, Singh, R, Madsen, D, Lolans, K, Lomovskaya, O, Oza, U, and Dudley, MN
Bioorg Med Chem Lett 2004. 14(20): 5133-7
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15380214&dopt=abstract
22. 44249 OI-LS-307; SCIFINDER-OI-10/14/2004
Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles
Walczak, Krzysztof, Gondela, Andrzej, and Suwinski, Jerzy
European Journal of Medicinal Chemistry 2004. 39(10): 849-853
23. 44250 OI-LS-307; SCIFINDER-OI-10/14/2004
The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli
Rivera-Marrero, Carlos A, Stewart, Julie, Shafer, William M, and Roman, Jesse
Infection and Immunity 2004. 72(10): 5712-5721
24. 44251 OI-LS-307; WOS-OI-10/10/2004
Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs
Davis, M, Rhodes, T, and Martin, A
SOCIAL SCIENCE & MEDICINE 2004. 59(9): 1807-1818, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223734100003
25. 44252 OI-LS-307; SCIFINDER-OI-10/14/2004
Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening
Hisert, Katherine B, Kirksey, Meghan A, Gomez, James E, Sousa, Alexandra O, Cox, Jeffery S, Jacobs, William R Jr, Nathan, Carl F, and McKinney, John D
Infection and Immunity 2004. 72(9): 5315-5321
26. 44253 OI-LS-307; SCIFINDER-OI-10/14/2004
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo
Garg, Sanjay K, Volpe, Elisabetta, Palmieri, Graziana, Mattei, Maurizio, Galati, Domenico, Martino, Angelo, Piccioni, Maria S, Valente, Emanuela, Bonnano, Elena, De Vito, Paolo, Baldini, Patrizia M, Spagnoli, Luigi G, Colizzi, Vittorio, and Fraziano, Maurizio
Journal of Infectious Diseases 2004. 189(11): 2129-2138
27. 44254 OI-LS-307; WOS-OI-10/10/2004
Regulation of hepatitis C virus replication by interferon regulatory factor 1
Kanazawa, N, Kurosaki, M, Sakamoto, N, Enomoto, N, Itsui, Y, Yamashiro, T, Tanabe, Y, Maekawa, S, Nakagawa, M, Chen, CH, Kakinuma, S, Oshima, S, Nakamura, T, Kato, T, Wakita, T, and Watanabe, M
JOURNAL OF VIROLOGY 2004. 78(18): 9713-9720, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223701100015
28. 44255 OI-LS-307; WOS-OI-10/10/2004
Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s)
Yang, G, Pevear, DC, Collett, MS, Chunduru, S, Young, DC, Benetatos, C, and Jordan, R
JOURNAL OF VIROLOGY 2004. 78(18): 10202-10205, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223701100065
29. 44256 OI-LS-307; SCIFINDER-OI-10/14/2004
Synthesis of some new cyanopyrans and cyanopyridines and their biological activities
Popat, KH, Kachhadia, VV, Nimavat, Kiran S, and Joshi, HS
Journal of the Indian Chemical Society 2004. 81(2): 157-159
30. 44257 OI-LS-307; SCIFINDER-OI-10/14/2004
Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis
Kuwabara, Katsuhiro, Watanabe, Yasushi, Wada, Koichi, and Tsuchiya, Toshiaki
Kekkaku 2004. 79(2): 39-46
31. 44258 OI-LS-307; WOS-OI-10/10/2004
HIV/HCV coinfection: Management update
Alvarez, D
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION 2004. 96(2): 25-26, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223740600007
32. 44259 OI-LS-307; SCIFINDER-OI-10/14/2004
Mycobacterium tuberculosis Growth Inhibition by Constituents of Sapium haematospermum
Woldemichael, Girma M, Gutierrez-Lugo, Maria-Teresa, Franzblau, Scott G, Wang, Yuehong, Suarez, Enrique, and Timmermann, Barbara N
Journal of Natural Products 2004. 67(4): 598-603
33. 44260 OI-LS-307; SCIFINDER-OI-10/14/2004
Fluoroquinolones as chemotherapeutics against mycobacterial infections
Jacobs, Michael R
Current Pharmaceutical Design 2004. 10(26): 3213-3220
34. 44261 OI-LS-307; SCIFINDER-OI-10/14/2004
Novel bacterial RNase P proteins and their use in identifying antibacterial compounds
Gopalan, Venkat, Jovanovic, Milan, Eder, Paul S, Giordano, Tony, Powers, Gordon D, and Xavier, KAsish
PATENT: US 2004127480 ISSUE DATE: 20040701
APPLICATION: 2001-12203 PP: 53 pp., Cont.-in-part of U.S. Ser. No. 516,061.
ASSIGNEE: (USA)
35. 44262 OI-LS-307; WOS-OI-10/10/2004
Is second-line anti-tuberculosis drug susceptibility testing reliable?
Kim, SJ, Espinal, MA, Abe, C, Bai, GH, Boulahbals, F, Fattorinit, L, Gilpin, C, Hoffner, S, Kam, KM, Martin-Casabona, N, Rigouts, L, and Vincent, V
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 2004. 8(9): 1157-1158, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223680300021
36. 44263 OI-LS-307; SCIFINDER-OI-10/14/2004
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations
Scott, GM, Isaacs, MA, Zeng, F, Kesson, AM, and Rawlinson, WD
Journal of Medical Virology 2004. 74(1): 85-93
37. 44264 OI-LS-307; SCIFINDER-OI-10/14/2004
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir
Margiotta, Nicola, Bergamo, Alberta, Sava, Gianni, Padovano, Giacomo, De Clercq, Erik, and Natile, Giovanni
Journal of Inorganic Biochemistry 2004. 98(8): 1385-1390
38. 44265 OI-LS-307; WOS-OI-10/10/2004
Silent nucleotide polymorphisms and a phyogeny for Mycobacterium tuberculosis
Baker, L, Brown, T, Maiden, MC, and Drobniewski, F
EMERGING INFECTIOUS DISEASES 2004. 10(9): 1568-1577, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223740200008
39. 44266 OI-LS-307; WOS-OI-10/10/2004
From penicillin to the ribosome: Revolutions in the determination and use of molecular structure in chemistry and biology
Baker, EN
AUSTRALIAN JOURNAL OF CHEMISTRY 2004. 57(9): 829-836, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223736700003
40. 44267 OI-LS-307; WOS-OI-10/10/2004
The synthesis of N-ribosyl transferase inhibitors based on a transition state blueprint
Evans, GB
AUSTRALIAN JOURNAL OF CHEMISTRY 2004. 57(9): 837-854, 18
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223736700004
41. 44268 OI-LS-307; SCIFINDER-OI-10/14/2004
Preparation of 4-thio substituted coumarin derivatives as anti-HCV agent
Wu, Jie, Yang, Zhen, Fathi, Reza, and Zhu, Qiang
PATENT: US 2004180950 ISSUE DATE: 20040916
APPLICATION: 2004-31758 PP: 43 pp., Cont.-in-part of U.S. Pat. Appl. 2004 2,538.
ASSIGNEE: (USA)
42. 44269 OI-LS-307; SCIFINDER-OI-10/14/2004
Infectious diseases. Part 4. Infections due to human immunodeficiency virus (HIV) and hepatitis-C virus (HCV)
Stock, Ingo
PZ Prisma 2004. 11(3): 188-198
43. 44270 OI-LS-307; SCIFINDER-OI-10/14/2004
Preparation of triazolyl nucleoside derivatives as Hepatitis C antiviral agents
Hendricks, Robert Than, Humphreys, Eric Roy, Martin, Joseph Armstrong, Prince, Anthony, and Sarma, Keshab
PATENT: WO 2004052905 ISSUE DATE: 20040624
APPLICATION: 2003 PP: 40 pp.
ASSIGNEE: (F. Hoffmann-La Roche Ag, Switz.
44. 44271 OI-LS-307; WOS-OI-10/17/2004
Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy
Kalita, A, Verma, I, and Khuller, GK
JOURNAL OF INFECTIOUS DISEASES 2004. 190(8): 1476-1480, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223968700015
45. 44272 OI-LS-307; SCIFINDER-OI-10/14/2004
Preparation of 6-methyl-2-(4-morpholinoanilino)nicotinic acid as anti-HCV agent
Kim, Jongwoo, Lee, Sangwook, Lee, Geunhyung, Han, Jaejin, Park, Sangjin, Park, Eulyong, and Shin, Joongchul
PATENT: WO 2004033450 ISSUE DATE: 20040422
APPLICATION: 2003 PP: 18 pp.
ASSIGNEE: (B & C Biopharm Co., Ltd. S. Korea
46. 44273 OI-LS-307; WOS-OI-10/17/2004
Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers
Kremer, K, Glynn, JR, Lillebaek, T, Niemann, S, Kurepina, NE, Kreiswirth, BN, Bifani, PJ, and van, Soolingen D
JOURNAL OF CLINICAL MICROBIOLOGY 2004. 42(9): 4040-4049, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223902000020
47. 44274 OI-LS-307; WOS-OI-10/17/2004
Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA
Cook, L, Ng, KW, Bagabag, A, Corey, L, and Jerome, KR
JOURNAL OF CLINICAL MICROBIOLOGY 2004. 42(9): 4130-4136, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223902000033
48. 44275 OI-LS-307; WOS-OI-10/17/2004
Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis
Srivastava, K, Das, R, Jakhmola, P, Gupta, P, Chauhan, DS, Sharma, VD, Singh, HB, Sachan, AS, and Katoch, VM
INDIAN JOURNAL OF MEDICAL RESEARCH 2004. 120(2): 100-105, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223870000008
49. 44276 OI-LS-307; WOS-OI-10/17/2004
Synthesis, spectroscopic studies, and crystal structures of phenylorganotin derivatives with [bis(2,6-dimethylphenyl)amino]benzoic acid: Novel antituberculosis agents
Dokorou, V, Kovala-Demertzi, D, Jasinski, JP, Galani, A, and Demertzis, MA
HELVETICA CHIMICA ACTA 2004. 87(8): 1940-1950, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223883200004
50. 44277 OI-LS-307; WOS-OI-10/17/2004
Anidulafungin: an echinocandin antifungal
Pfaller, MA
EXPERT OPINION ON INVESTIGATIONAL DRUGS 2004. 13(9): 1183-1197, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223845700009
51. 44278 OI-LS-307; WOS-OI-10/17/2004
Ring-substituted imidazoles as a new class of anti-tuberculosis agents
Gupta, P, Hameed, S, and Jain, R
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2004. 39(9): 805-814, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223874100008
52. 44279 OI-LS-307; WOS-OI-10/17/2004
Expression and characterization of the protein Rv1399c from Mycobacterium tuberculosis - A novel carboxyl esterase structurally related to the HSL family
Canaan, S, Maurin, D, Chahinian, H, Pouilly, B, Durousseau, C, Frassinetti, F, Scappuccini-Calvo, L, Cambillau, C, and Bourne, Y
EUROPEAN JOURNAL OF BIOCHEMISTRY 2004. 271(19): 3953-3961, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223954800016
53. 44280 OI-LS-307; WOS-OI-10/17/2004
Identification and validation of novel drug targets in tuberculosis
Duncan, K
CURRENT PHARMACEUTICAL DESIGN 2004. 10(26): 3185-3194, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223854000002
54. 44281 OI-LS-307; WOS-OI-10/17/2004
Structural bioinformatic approaches to the discovery of new antimycobacterial drugs
Kantardjieff, K and Rupp, B
CURRENT PHARMACEUTICAL DESIGN 2004. 10(26): 3195-3211, 17
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=00022385400000355. 44282 OI-LS-307; WOS-OI-10/17/2004
Liposome technology for drug delivery against mycobacterial infections
Khuller, GK, Kapur, M, and Sharma, S
CURRENT PHARMACEUTICAL DESIGN 2004. 10(26): 3263-3274, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223854000008
56. 44283 OI-LS-307; WOS-OI-10/17/2004
Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs
Mitchison, DA and Coates, ARM
CURRENT PHARMACEUTICAL DESIGN 2004. 10(26): 3285-3295, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223854000010
57. 44284 OI-LS-307; WOS-OI-10/17/2004
Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research
Varma, MVS, Khandavilli, S, Ashokraj, Y, Jain, A, Dhanikula, A, Sood, A, Thomas, NS, Pillai, O, Sharma, P, Gandhi, R, Agrawal, S, Nair, V, and Panchagnula, R
CURRENT DRUG METABOLISM 2004. 5(5): 375-388, 14
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223854300002
58. 44285 OI-LS-307; WOS-OI-10/17/2004
Human Hepatocytes in primary culture: The choice to investigate drug metabolism in man
Gomez-Lechon, MJ, Donato, MT, Castell, JV, and Jover, R
CURRENT DRUG METABOLISM 2004. 5(5): 443-462, 20
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223854300006
59. 44286 OI-LS-307; WOS-OI-10/17/2004
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab ')(2) fragment prolong survival of mice infected with Mycobacterium tuberculosis
Hamasur, B, Haile, M, Pawlowski, A, Schroder, U, Kallenius, G, and Svenson, SB
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2004. 138(1): 30-38, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223953500005
60. 44287 OI-LS-307; WOS-OI-10/17/2004
Combined effect of atovaquone and pyrrolidine dithiocarbamate in the treatment of acute murine toxoplasmosis
Djurkovic-Djakovic, O, Nikolic, A, Bobic, B, and Klun, I
CHEMOTHERAPY 2004. 50(3): 155-156, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223897900009
61. 44288 OI-LS-307; WOS-OI-10/17/2004
Antimycobacterial 1-aryl-5-benzylsulfanyltetrazoles
Waisser, K, Adamec, J, Kunes, J, and Kaustova, B
CHEMICAL PAPERS-CHEMICKE ZVESTI 2004. 58(3): 214-219, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223853100013